Application of a human multidrug transporter (ABCG2) variant as selectable marker in gene transfer to progenitor cells

Hum Gene Ther. 2003 Mar 1;14(4):403-12. doi: 10.1089/104303403321209005.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily G, Member 2
  • ATP-Binding Cassette Transporters / genetics*
  • Antigens, CD34 / analysis
  • Biomarkers / analysis
  • Cell Death
  • Cells, Cultured
  • Flow Cytometry
  • Genes, Reporter
  • Genetic Therapy
  • Genetic Vectors
  • Granulocytes / enzymology
  • Granulocytes / immunology
  • Granulomatous Disease, Chronic / therapy
  • Hematopoietic Stem Cells / metabolism*
  • Humans
  • Immunohistochemistry
  • Membrane Glycoproteins / genetics*
  • Membrane Glycoproteins / metabolism
  • Mitoxantrone / pharmacology
  • Mitoxantrone / toxicity
  • Mutation
  • NADPH Oxidase 2
  • NADPH Oxidases / genetics*
  • Neoplasm Proteins*
  • Recombination, Genetic
  • Retroviridae / genetics
  • Transduction, Genetic
  • Tumor Cells, Cultured

Substances

  • ABCG2 protein, human
  • ATP Binding Cassette Transporter, Subfamily G, Member 2
  • ATP-Binding Cassette Transporters
  • Antigens, CD34
  • Biomarkers
  • Membrane Glycoproteins
  • Neoplasm Proteins
  • Mitoxantrone
  • CYBB protein, human
  • NADPH Oxidase 2
  • NADPH Oxidases